ID

31965

Beschreibung

Study ID: 105229 Clinical Study ID: GLP105229 Study Title: A double-blinded, randomized, placebo-controlled, staggered-parallel, escalating dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneous injections of GSK 716155 in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Stichworte

Versionen (2)
  1. 09.10.18 09.10.18 -
  2. 09.10.18 09.10.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

9. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Subcutaneous injections of GSK 716155 in healthy volunteers; Study ID: 105229

Englisch

Day 21

1 Formulare  
  1. StudyEvent: ODM
    1. Day 21
Electronically transferred Laboratory Data - Fructosamine
Beschreibung

Electronically transferred Laboratory Data - Fructosamine

Alias
UMLS CUI-1
C0202025
Date Sample Taken
Beschreibung

Fructosamine measurement; Sampling, Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0202025
UMLS CUI [1,2]
C0870078
UMLS CUI [1,3]
C0011008
Actual Time
Beschreibung

Fructosamine measurement; Sampling; Time

Datentyp

time

Alias
UMLS CUI [1,1]
C0202025
UMLS CUI [1,2]
C0870078
UMLS CUI [1,3]
C0040223
Immunogenicity Testing; Blood
Beschreibung

Immunogenicity Testing; Blood

Alias
UMLS CUI-1
C4054739
UMLS CUI-2
C0005767
Planned Relative Time
Beschreibung

Immunogenicity Study; Blood; relative time

Datentyp

text

Alias
UMLS CUI [1,1]
C4054739
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0439564
Date Sample Taken
Beschreibung

Pharmacokinetic aspects; Blood; Sampling; Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0870078
UMLS CUI [1,4]
C0011008
Actual Time
Beschreibung

Pharmacokinetic aspects; Blood; Sampling; Time

Datentyp

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0040223
Sample Number
Beschreibung

Pharmacokinetic aspects; Blood; Sample identification number

Datentyp

integer

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C1299222
Pharmacokinetic aspects; Blood
Beschreibung

Pharmacokinetic aspects; Blood

Alias
UMLS CUI-1
C0005834
UMLS CUI-2
C0031328
Planned Relative Time
Beschreibung

Pharmacokinetic aspects; Blood; relative time

Datentyp

text

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0439564
Date Sample Taken
Beschreibung

Pharmacokinetic aspects; Blood; Sampling; Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0870078
UMLS CUI [1,4]
C0011008
Actual Time
Beschreibung

Pharmacokinetic aspects; Blood; Sampling; Time

Datentyp

time

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C0870078
UMLS CUI [1,4]
C0040223
Sample Number
Beschreibung

Pharmacokinetic aspects; Blood; Sample identification number

Datentyp

integer

Alias
UMLS CUI [1,1]
C0031328
UMLS CUI [1,2]
C0005767
UMLS CUI [1,3]
C1299222
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Day 21

1 Formulare
  1. StudyEvent: ODM
    1. Day 21
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Electronically transferred Laboratory Data - Fructosamine
C0202025 (UMLS CUI-1)
Fructosamine measurement; Sampling, Date
Item
Date Sample Taken
date
C0202025 (UMLS CUI [1,1])
C0870078 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Fructosamine measurement; Sampling; Time
Item
Actual Time
time
C0202025 (UMLS CUI [1,1])
C0870078 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item Group
Immunogenicity Testing; Blood
C4054739 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
Item
Planned Relative Time
text
C4054739 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0439564 (UMLS CUI [1,3])
Immunogenicity Study; Blood; relative time
Code List
Planned Relative Time
CL Item
Day 21 (Day 21)
Pharmacokinetic aspects; Blood; Sampling; Date in time
Item
Date Sample Taken
date
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Pharmacokinetic aspects; Blood; Sampling; Time
Item
Actual Time
time
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
Item
Sample Number
integer
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,3])
Pharmacokinetic aspects; Blood; Sample identification number
Code List
Sample Number
CL Item
502 (1)
Item Group
Pharmacokinetic aspects; Blood
C0005834 (UMLS CUI-1)
C0031328 (UMLS CUI-2)
Item
Planned Relative Time
text
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0439564 (UMLS CUI [1,3])
Pharmacokinetic aspects; Blood; relative time
Code List
Planned Relative Time
CL Item
Any time (Any time)
Pharmacokinetic aspects; Blood; Sampling; Date in time
Item
Date Sample Taken
date
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Pharmacokinetic aspects; Blood; Sampling; Time
Item
Actual Time
time
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
Item
Sample Number
integer
C0031328 (UMLS CUI [1,1])
C0005767 (UMLS CUI [1,2])
C1299222 (UMLS CUI [1,3])
Pharmacokinetic aspects; Blood; Sample identification number
Code List
Sample Number
CL Item
118 (1)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video